SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-017882
Filing Date
2024-05-06
Accepted
2024-05-06 13:56:06
Documents
4
Period of Report
2024-05-06

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 782018
2 formdef14a_001.jpg GRAPHIC 5037
3 proxy_001.jpg GRAPHIC 311941
4 proxy_002.jpg GRAPHIC 326835
  Complete submission text file 0001493152-24-017882.txt   1670442
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36457 | Film No.: 24916834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)